PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Sciformix Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Sciformix to Showcase Next Generation Pharmacovigilance Approaches at the World Drug Safety Congress Europe - Proactive PV approaches address operational excellence to facilitate on going quality and compliance coupled with process effectiveness - Sciformix.com
Sciformix to Showcase Next Generation Pharmacovigilance Approaches at the World Drug Safety Congress Europe

 

NewswireToday - /newswire/ - Boston, MA, United States, 2014/08/26 - Proactive PV approaches address operational excellence to facilitate on going quality and compliance coupled with process effectiveness - Sciformix.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Sciformix Corporation, a leading Scientific Process Organization (SPO), will showcase proactive pharmacovigilance (PV) approaches and best practices at this year’s World Drug Safety Congress (WDSC) Europe, which will take place in London, 10-11 September. These approaches will allow the pharma industry to address increasingly stringent PV requirements along with global expansion and increasing workloads.

The presentation entitled ‘Next Generation PV Achieving Operational Excellence to Ensure Compliance and Quality’, to be delivered by Boris Jankowski, Director of Solutions Architecture at Sciformix in the Woburn Suite at 15:20 BST on Wednesday 10th September, will outline the strategic challenges facing marketing authorization holders and how they can implement various models to facilitate compliance with the evolving global regulatory requirements. The presentation will go on to provide best practices in working with partners to deliver end-to-end pharmacovigilance services.

Mr Jankowski, commented: “The on-going regulatory developments and the industry’s expansion into emerging markets have substantially raised the bar for conducting pharmacovigilance on a global scale. In order to meet these challenges, new proactive approaches in delivering pharmacovigilance services are required. While the presentation at WDSC will provide delegates with best practices in achieving operational excellence, it will also convey the opportunities and challenges related to the evolving global corporate and regulatory changes, and how these influence the new PV operating models.”

He continued: “The current regulatory environment dictates that it is vital for companies to understand how to assure organizational readiness for the externalizations of PV activities, as well as what an optimized partnership model should look like so that companies can employ operational excellence and achieve on-going quality and compliance. The WDSC is a fantastic opportunity for the industry as a whole to come together and foster a greater understanding of the new drug safety/PV initiatives, the global regulatory environment and the associated complexities affecting the management of drug safety. Together with this, we are provided with a platform for discussion and planning on what the future of drug safety will hold.”

The 7th WDSC, taking place at The Hotel Russell, London, will embrace key aspects of pharmacovigilance, signal detection, clinical safety, regulations and benefit risk management. Spanning two days, the congress will focus on the international drug safety landscape, the global regulatory environment, increasing complexities affecting the management of drug safety, data management and electronic submissions, financial and logistical constraints, clinical safety and the limitations to pre-marketing safety.

To meet with Sciformix at WDSC and/or receive a copy of the presentation, contact us at Bizteam[.]sciformix.com.

Contact: David Bertram, The Scott Partnership
P: +44(0)14 7753 9539 - E: ciformix[.]scottpr.com.

About Sciformix
Sciformix Corporation (sciformix.com) is a leading Scientific Process Organization (SPO), providing scientific knowledge-based services to pharmaceutical and biopharmaceutical, generics, consumer products, medical devices and other healthcare companies in the areas of Safety and Risk Management, Clinical Research & Post-Approval Support and Regulatory Affairs. Our mission is to partner with global life science companies to provide high quality scientific knowledge-based expertise to deliver better quality outcomes and improved efficiencies across the entire product lifecycle with the ultimate objective of improving quality of healthcare for patients worldwide. Corporate headquarters is located in Westborough, MA with operations in USA, India and the Philippines.

We create value for our clients through our singular focus on the life sciences industry, strong pharmaceutical domain competency, exceptional subject matter expertise, industry reputed advisory board, uncompromising focus on quality, process rigor, predictable results, and ability to scale. Our portfolio of services spans the full spectrum of product lifecycle from pre-clinical and clinical to post marketing activities to help our customers solve complex analytical challenges, improve the quality of patient healthcare and increase client productivity.

Sciformix is dedicated to providing our clients outstanding services and solutions, fuelled by an unrivalled commitment to quality. We share the same level of involvement, dedication and passion as our clients and become an integral part of their team. Our distinct combination of scientific expertise, process rigor and technology innovation delivers consistent, reliable and insightful results. Our ability to scale and grow to meet your evolving needs means we are flexible and dedicated to your success in delivering safe products with more efficiency and greater speed. We help you make the right decisions at the right time by providing Trusted Services Built on Science.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Sciformix Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Sciformix to Showcase Next Generation Pharmacovigilance Approaches at the World Drug Safety Congress Europe

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Sciformix Corporation | WDSC
Publisher Contact: Susan Najjar - Sciformix.com 
617-264-0339 susan.najjar[.]sciformix.com / ask[.]sciformix.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sciformix Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Sciformix Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians
Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)